Birdwatch Note
2022-10-17 16:44:46 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Burzynski’s antineoplaston therapies as cancer cures have been studied and found to be ineffective. The FDA has issued warnings about their cost to patients, basically selling false hope to the desperate. Well-regarded doctors consider them quackery at this point. https://sciencebasedmedicine.org/my-cancer-free-life-a-reality-series-designed-to-promote-stanislaw-burzynskis-quackery/
Written by EBC8CCD43363C7C1F341CB3C0B6FD1E7
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1581749838676647936
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1582049994579877890
- noteId - 1582049994579877890
- participantId - EBC8CCD43363C7C1F341CB3C0B6FD1E7
- noteAuthorParticipantId -
- createdAtMillis - 1666025086433
- tweetId - 1581749838676647936
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - CHALLENGING
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Burzynski’s antineoplaston therapies as cancer cures have been studied and found to be ineffective. The FDA has issued warnings about their cost to patients, basically selling false hope to the desperate. Well-regarded doctors consider them quackery at this point. https://sciencebasedmedicine.org/my-cancer-free-life-a-reality-series-designed-to-promote-stanislaw-burzynskis-quackery/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-10-17 16:44:46 UTC (1666025086433) |
2022-10-18 06:42:22 UTC (1666075342407) |
CURRENTLY_RATED_HELPFUL | 2022-10-18 06:42:22 UTC (1666075342407) |
CURRENTLY_RATED_HELPFUL | 2022-10-18 06:42:22 UTC (1666075342407) |
CURRENTLY_RATED_HELPFUL | 198E251855038267D37E76C0C948AD04F3278C9791E301C950FD127F3D1C552A |
2022-10-17 16:44:46 UTC (1666025086433) |
2022-10-18 06:42:22 UTC (1666075342407) |
CURRENTLY_RATED_HELPFUL | 2022-10-18 06:42:22 UTC (1666075342407) |
CURRENTLY_RATED_HELPFUL | 2022-10-18 06:42:22 UTC (1666075342407) |
CURRENTLY_RATED_HELPFUL | EBC8CCD43363C7C1F341CB3C0B6FD1E7 |
Note Ratings
rated at | rated by | |
2022-10-17 15:14:13 -0500 | 028F48873A5696E7478BF402924D4B6D | Rating Details |
2022-10-18 08:18:35 -0500 | 0AB689C453F1E569091558B03440721F | Rating Details |
2022-10-17 17:05:15 -0500 | 0C91900F7892D8DA899BB85193A8758A | Rating Details |
2022-10-20 07:11:20 -0500 | 152C664EC474246EB3D5BD53CBEFF1A9 | Rating Details |
2022-10-19 11:56:29 -0500 | 227B72516F48209D4CD398BD566B39A53B64980200BCA4A4C749072F49AA8384 | Rating Details |
2022-10-17 19:03:03 -0500 | 31FB79A53AE9E1FA6FB3440FD0549F856D1187F07960AEDD3E4D088170F103BE | Rating Details |
2022-10-18 06:12:06 -0500 | 3280545D607EB56DF3C31042F9397E2C | Rating Details |
2022-10-18 00:42:16 -0500 | 3D91134D4D78BA77FCD65E135838A3ADCB8EA4BB850004E334DCF5B97380BFAA | Rating Details |
2022-10-19 15:46:18 -0500 | 3F600481286CF21822B14CDFEF8114C2A596D61F988CA0B90A56E584F9D3C694 | Rating Details |
2022-10-17 18:29:44 -0500 | 45DB2450D1DEA41B88C09B55898707CB | Rating Details |
2022-10-18 13:06:02 -0500 | 4C9C9C9232A2FFC3397EF49BC82CD9F579BE5769129385A4CF22FF562AB61777 | Rating Details |
2022-10-17 18:09:51 -0500 | 51CF24E741A18508E181F80408E6E7E109FDDE98B31A9F11F05480731FF485A6 | Rating Details |
2022-10-17 18:09:51 -0500 | 5AD0B5581E4AC4683F4A8D75DEB62680 | Rating Details |
2022-10-18 01:41:59 -0500 | 5E029615EC0F56F0AC8292EB665B1FF9ECD69BEA1F1587C53E5F90C72C918DF8 | Rating Details |
2022-10-17 22:29:16 -0500 | 62BB8A0FEDBCA117D562B280783DF09B6F37E761972BAF2FB218C83A3E22EDC9 | Rating Details |
2022-10-18 13:06:02 -0500 | 6BC5833BC8B9DE0CEDADD4D697F09335 | Rating Details |
2022-10-17 23:19:01 -0500 | 6F61D96BC91921AAEA3A47009B58F81E8F9815DB4F57E1E8EEEBFD9F27BB0999 | Rating Details |
2022-10-17 15:14:13 -0500 | 6F63CC79CAC0EDCE3AAAF0923FFC97BF7DEDD3FA0E92DB04EC111936BA5E3635 | Rating Details |
2022-10-17 22:29:16 -0500 | 76367B145F13EF8DB3180BB4BA72FA0C | Rating Details |
2022-10-17 16:17:59 -0500 | 8287473C23000581E5B9AA8BA49800DB | Rating Details |
2022-10-17 15:53:22 -0500 | 87F9A3AD36213601F705EC926F742E9B | Rating Details |
2022-10-18 00:42:16 -0500 | 884663533B63E30AFE942DD8D5C55D27 | Rating Details |
2022-10-18 01:41:59 -0500 | 8DD6287026A2737B9E0770B35BC5264D | Rating Details |
2022-10-17 18:29:44 -0500 | 92B6C4F354B863069D8FDCFCE28AD9A700129A6CA43609CBA4A68E9ECA8E55AA | Rating Details |
2022-10-17 19:55:55 -0500 | 989E2C74ED5B504631C9CF02D77F343E1405C57409BD69187EF94640D4BE4442 | Rating Details |
2022-10-20 07:11:20 -0500 | A227869B752DF62F7538C29F2D2D225BAE499F3095FF33A985D81DD1C622A0E8 | Rating Details |
2022-10-17 17:05:15 -0500 | A30E23B01F927C4387616E33DE422C96B4F9A9B45B8ACA619267391F3D77B5A8 | Rating Details |
2022-10-17 23:19:01 -0500 | A43FD0B2F35BB07CD3D84AA2A2ECAF26 | Rating Details |
2022-10-18 08:18:35 -0500 | A85F927C9E2230CA97A16F2D42A0863AE8F865C26076FFD7493E49F75D5CC756 | Rating Details |
2022-10-18 06:12:06 -0500 | ADD6D84E1F57E6163E655F2B417E4696E606ADB54DD1EDE679CED0D4F3222ABD | Rating Details |
2022-10-17 15:53:22 -0500 | B1C5C2AFA728FEA2FB000676C4042D8A4B1414189951660003FAB89BECD98269 | Rating Details |
2022-10-19 11:56:29 -0500 | B47391ADD314142E98ADB1447C70FB98 | Rating Details |
2022-10-17 16:17:59 -0500 | EEA39E8B4AB1BEFA47B775A2CE4DCDDD073841F27C81F5E281FC7C6F7F045296 | Rating Details |
2022-10-17 21:35:27 -0500 | F092EA4CB202B72F79AC43DE5CAF2DC7D60778EB0698DDEA8AB3EED4323C2245 | Rating Details |
2022-10-17 19:55:55 -0500 | FB4E5DF6ED9FE258CEFC55E5C7A6F76B | Rating Details |
2022-10-17 21:35:27 -0500 | FBD4C539ADDD48521B69767302DD70B1 | Rating Details |
2022-10-17 16:17:59 -0500 | Rating Details | |
2022-10-17 18:29:44 -0500 | Rating Details | |
2022-10-18 01:41:59 -0500 | Rating Details | |
2022-10-20 07:11:20 -0500 | Rating Details | |
2022-10-18 08:18:35 -0500 | Rating Details | |
2022-10-17 15:53:22 -0500 | Rating Details | |
2022-10-18 00:42:16 -0500 | Rating Details | |
2022-10-18 06:12:06 -0500 | Rating Details | |
2022-10-17 19:55:55 -0500 | Rating Details | |
2022-10-19 15:46:18 -0500 | Rating Details | |
2022-10-17 22:29:16 -0500 | Rating Details | |
2022-10-17 19:03:03 -0500 | Rating Details | |
2022-10-17 17:05:15 -0500 | Rating Details | |
2022-10-17 18:09:51 -0500 | Rating Details | |
2022-10-18 13:06:02 -0500 | Rating Details | |
2022-10-17 23:19:01 -0500 | Rating Details | |
2022-10-19 11:56:29 -0500 | Rating Details |